secwatch.observer — SEC 8-K summary
======================================

Issuer:     MASIMO CORP (MASI)
CIK:        0000937556
Form:       8-K
Filed at:   2023-11-07T23:59:59+00:00
Accession:  0000937556-23-000217
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Masimo appoints Rolf Classon to board of directors
--------------------------------------------------

- Rolf A. Classon appointed as a Class II director effective November 3, 2023.
- Classon is a former Bayer HealthCare executive with board seats at Fresenius Medical Care, Catalent, and others.
- Annual cash compensation of $70,000 plus initial RSU grant valued at $200,000 at next annual meeting.
- No family relationships or related-party transactions with Masimo officers/directors.
- Classon will help shape next stage of growth, per Chairman and CEO Joe Kiani.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/937556/000093755623000217/0000937556-23-000217-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/937556/000093755623000217/masi-20231103.htm
  HTML page:      https://secwatch.observer/filing/0000937556-23-000217

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer